Luxin Venture Capital Group Past Earnings Performance
Past criteria checks 1/6
Luxin Venture Capital Group has been growing earnings at an average annual rate of 15.2%, while the Chemicals industry saw earnings growing at 7.8% annually. Revenues have been declining at an average rate of 17.7% per year. Luxin Venture Capital Group's return on equity is 0.2%, and it has net margins of 13.6%.
Key information
15.2%
Earnings growth rate
15.2%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | -17.7% |
| Return on equity | 0.2% |
| Net Margin | 13.6% |
| Next Earnings Update | 31 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Luxin Venture Capital Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 82 | 11 | 122 | 4 |
| 31 Dec 23 | 80 | 254 | 123 | 4 |
| 30 Sep 23 | 121 | 468 | 144 | 5 |
| 30 Jun 23 | 106 | 552 | 143 | 4 |
| 31 Mar 23 | 108 | 523 | 146 | 5 |
| 31 Dec 22 | 116 | 481 | 144 | 5 |
| 30 Sep 22 | 120 | 344 | 133 | 4 |
| 30 Jun 22 | 129 | 478 | 124 | 4 |
| 31 Mar 22 | 133 | 611 | 113 | 4 |
| 31 Dec 21 | 135 | 509 | 109 | 5 |
| 30 Sep 21 | 132 | 87 | 96 | 5 |
| 30 Jun 21 | 134 | 500 | 92 | 6 |
| 31 Mar 21 | 127 | 313 | 91 | 5 |
| 31 Dec 20 | 121 | 335 | 104 | 5 |
| 30 Sep 20 | 142 | 609 | 95 | 7 |
| 30 Jun 20 | 154 | 206 | 101 | 9 |
| 31 Mar 20 | 188 | 139 | 109 | 11 |
| 31 Dec 19 | 222 | 224 | 105 | 12 |
| 30 Sep 19 | 212 | 39 | 102 | 17 |
| 30 Jun 19 | 220 | 1 | 102 | 17 |
| 31 Mar 19 | 215 | 215 | 105 | 16 |
| 31 Dec 18 | 207 | 187 | 105 | 14 |
| 30 Sep 18 | 214 | 14 | 69 | 7 |
| 30 Jun 18 | 211 | 92 | 120 | 7 |
| 31 Mar 18 | 218 | 54 | 66 | 5 |
| 31 Dec 17 | 216 | 43 | 66 | 4 |
| 30 Sep 17 | 201 | 287 | 98 | 2 |
| 30 Jun 17 | 201 | 254 | 37 | 0 |
| 31 Mar 17 | 193 | 349 | 96 | 0 |
| 31 Dec 16 | 186 | 373 | 94 | 0 |
| 30 Sep 16 | 189 | 327 | 124 | 0 |
| 30 Jun 16 | 184 | 308 | 126 | 0 |
| 31 Mar 16 | 190 | 191 | 131 | 0 |
| 31 Dec 15 | 191 | 224 | 129 | 0 |
| 30 Sep 15 | 211 | 212 | 85 | 0 |
| 30 Jun 15 | 222 | 349 | 105 | 0 |
| 31 Mar 15 | 223 | 326 | 84 | 0 |
| 31 Dec 14 | 235 | 302 | 85 | 0 |
| 30 Sep 14 | 239 | 360 | 124 | 0 |
| 30 Jun 14 | 238 | 294 | 112 | 0 |
| 31 Mar 14 | 236 | 335 | 116 | 0 |
| 31 Dec 13 | 235 | 310 | 115 | 0 |
| 30 Sep 13 | 221 | 289 | 109 | 0 |
Quality Earnings: 600783 has a large one-off loss of CN¥103.8M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 600783's current net profit margins (13.6%) are lower than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600783's earnings have grown by 15.2% per year over the past 5 years.
Accelerating Growth: 600783's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 600783 had negative earnings growth (-97.9%) over the past year, making it difficult to compare to the Chemicals industry average (-16.4%).
Return on Equity
High ROE: 600783's Return on Equity (0.2%) is considered low.